This inventor holds 2 USPTO granted patents. Top assignee: Baxter Laboratories, Inc.. Active years: 1976-1977.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976-1977
Title: Innovations by Guido A Ordonez
Introduction
Guido A Ordonez is a notable inventor based in Laguna Beach, California. He has made significant contributions to the field of biomedical engineering, particularly in the area of blood plasma fractionation. With a total of two patents to his name, Ordonez has developed innovative methods that enhance the preparation of vital blood components.
Latest Patents
Ordonez's latest patents include a method for the preparation of albumin by fractionation of blood plasma or serum. This method involves the selective precipitation of coagulation factor-depleted blood serum or plasma using block copolymers of ethylene oxide and polyoxypropylene polymer. This innovative approach provides immunoglobulin preparations, albumin-containing fractions, and organ perfusates. Another patent focuses on the fractionation of blood using a similar block copolymer technique, further emphasizing his expertise in this specialized area.
Career Highlights
Guido A Ordonez is currently associated with Baxter Laboratories, Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in medical treatments and technologies.
Collaborations
Ordonez collaborates with various professionals in his field, including his coworker Luis A Garcia. Their combined efforts aim to push the boundaries of current medical technologies and improve patient outcomes.
Conclusion
Guido A Ordonez stands out as an influential inventor in the biomedical field, with his patents reflecting a commitment to innovation and improvement in blood component preparation. His work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
